GILEAD SCIENCES, INC. — Net Income by Fiscal Year
19 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/530b851b-6376-460a-b3ec-670a89cf68c4/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $8.5B | 2025-01-01 – 2025-12-31 | evidence 0000882095-26-000006 |
| FY 2024 | $480.0M | 2024-01-01 – 2024-12-31 | evidence 0000882095-25-000006 |
| FY 2023 | $5.7B | 2023-01-01 – 2023-12-31 | evidence 0000882095-24-000007 |
| FY 2022 | $4.6B | 2022-01-01 – 2022-12-31 | evidence 0000882095-23-000007 |
| FY 2021 | $6.2B | 2021-01-01 – 2021-12-31 | evidence 0000882095-22-000007 |
| FY 2020 | $123.0M | 2020-01-01 – 2020-12-31 | evidence 0000882095-21-000008 |
| FY 2019 | $5.4B | 2019-01-01 – 2019-12-31 | evidence 0000882095-20-000006 |
| FY 2018 | $5.5B | 2018-01-01 – 2018-12-31 | evidence 0000882095-19-000006 |
| FY 2017 | $4.6B | 2017-01-01 – 2017-12-31 | evidence 0000882095-18-000008 |
| FY 2016 | $13.5B | 2016-01-01 – 2016-12-31 | evidence 0000882095-17-000006 |
| FY 2015 | $18.1B | 2015-01-01 – 2015-12-31 | evidence 0000882095-16-000039 |
| FY 2014 | $12.1B | 2014-01-01 – 2014-12-31 | evidence 0000882095-15-000008 |
| FY 2013 | $3.1B | 2013-01-01 – 2013-12-31 | evidence 0000882095-15-000008 |
| FY 2012 | $2.6B | 2012-01-01 – 2012-12-31 | evidence 0000882095-15-000008 |
| FY 2011 | $2.8B | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-075335 |
| FY 2010 | $2.9B | 2010-01-01 – 2010-12-31 | evidence 0001193125-11-050041 |
| FY 2009 | $2.6B | 2009-01-01 – 2009-12-31 | evidence 0001193125-10-044753 |
| FY 2008 | $2.0B | 2008-01-01 – 2008-12-31 | evidence 0001193125-10-044753 |
| FY 2007 | $1.6B | 2007-01-01 – 2007-12-31 | evidence 0001193125-10-044753 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GILEAD SCIENCES, INC. — all facts · Revenue · Operating Income